Cookie Img
Home » Products » Breast Cancer Drugs » Lapatinib Ditosylate Tablet

Lapatinib Ditosylate Tablet

Lapatinib Ditosylate Tablet
Lapatinib Ditosylate Tablet
Product Code : 135
Brand Name : Tykerb
Product Description

Lapatinib Ditosylate Tablet

Lapatinib is an anti-cancer drug used as a treatment for solid tumours such as breast and lung cancer. It was approved by the FDA on March 13, 2007, for use in patients with advanced metastatic breast cancer in conjunction with the chemotherapy drug Capecitabine. Lapatinib is human epidermal growth factor receptor type 2 (HER2/ERBB2) and epidermal growth factor receptor (HER1/EGFR/ERBB1) tyrosine kinases inhibitor. It binds to the intracellular phosphorylation domain to prevent receptor autophosphorylation upon ligand binding.

Features:

  • Utmost effectiveness
  • Treats advanced breast cancer
  • Precise composition
  • Accurate level of pH
Trade Information
  • Main Export Market(s)
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia

DHEER HEALTHCARE PRIVATE LIMITED

Contact Us

( *represents compulsory fields )

Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



DHEER HEALTHCARE PRIVATE LIMITED All Rights Reserved.